Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | ALG8 CL E G H | 79053 | 23161 | OMIM:608104 | Congenital disorder of glycosylation, type Ih | | | | 46 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | | | | 404 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | CPE CL E G H | 1363 | 2303 | OMIM:619326 | BDV SYNDROME; BDVS | | | | | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | DIO1 CL E G H | 1733 | 2883 | OMIM:619855 | | | | | | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 121 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:226316 | Genetic transient congenital hypothyroidism | | | | 121 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | DUOXA2 CL E G H | 405753 | 32698 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 11 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | FOCAD CL E G H | 54914 | 23377 | OMIM:619991 | | | | | 3 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | IRS4 CL E G H | 8471 | 6128 | OMIM:301035 | HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9; CHNG9 | | | | | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | IYD CL E G H | 389434 | 21071 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 130 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | KCNJ18 CL E G H | 100134444 | 39080 | OMIM:613239 | Thyrotoxic periodic paralysis, susceptibility to, 2 | | | | 10 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | MADD CL E G H | 8567 | 6766 | OMIM:619004 | DEEAH SYNDROME; DEEAH | | | | 5 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 63 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 63 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 63 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | NDN CL E G H | 4692 | 7675 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | NDN CL E G H | 4692 | 7675 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | NDN CL E G H | 4692 | 7675 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | OCA2 CL E G H | 4948 | 8101 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 121 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 121 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 121 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | PAX8 CL E G H | 7849 | 8622 | OMIM:218700 | Hypothyroidism, congenital, nongoitrous, 2 | | | | 63 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | POU1F1 CL E G H | 5449 | 9210 | OMIM:613038 | Pituitary hormone deficiency, combined, 1 | | | | 36 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | SECISBP2 CL E G H | 79048 | 30972 | ORPHA:171706 | Short stature-delayed bone age due to thyroid hormone metabolism deficiency | | | | 3 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | SECISBP2 CL E G H | 79048 | 30972 | OMIM:609698 | Thyroid hormone metabolism, abnormal | | | | 3 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | SLC5A5 CL E G H | 6528 | 11040 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 59 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | SNRPN CL E G H | 6638 | 11164 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 37 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 37 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 37 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TBL1X CL E G H | 6907 | 11585 | OMIM:301033 | Hypothyroidism, congenital, nongoitrous, 8 | | | | 1 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TG CL E G H | 7038 | 11764 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 155 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TG CL E G H | 7038 | 11764 | OMIM:274700 | Thyroid hormonogenesis, genetic defect in, 3 | | | | 155 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | THRA CL E G H | 7067 | 11796 | OMIM:614450 | Hypothyroidism, congenital, nongoitrous, 6 | | | | 9 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | THRB CL E G H | 7068 | 11799 | OMIM:188570 | Thyroid hormone resistance, generalized, autosomal dominant | | | | 161 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | THRB CL E G H | 7068 | 11799 | OMIM:274300 | Thyroid hormone resistance, generalized, autosomal recessive | | | | 161 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TPO CL E G H | 7173 | 12015 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 92 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TPO CL E G H | 7173 | 12015 | OMIM:274500 | Thyroid hormonogenesis, genetic defect in, 2A | | | | 92 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TRHR CL E G H | 7201 | 12299 | OMIM:618573 | HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7; CHNG7 | | | | 2 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TRHR CL E G H | 7201 | 12299 | ORPHA:99832 | Resistance to thyrotropin-releasing hormone syndrome | | | | 2 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TSHB CL E G H | 7252 | 12372 | ORPHA:90674 | Isolated thyroid-stimulating hormone deficiency | | | | 9 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TSHR CL E G H | 7253 | 12373 | OMIM:603373 | HYPERTHYROIDISM, FAMILIAL GESTATIONAL | | | | 97 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | TSHR CL E G H | 7253 | 12373 | ORPHA:90673 | Hypothyroidism due to TSH receptor mutations | | | | 97 | | |
HP:0031508 | HP:0031508 | Abnormal circulating thyroid hormone concentration | 0 | USP9X CL E G H | 8239 | 12632 | ORPHA:480880 | X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability | HP:0040283 - Occasional | | | 27 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | ALG8 CL E G H | 79053 | 23161 | OMIM:608104 | Congenital disorder of glycosylation, type Ih | | | | 46 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | | | | 404 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | CPE CL E G H | 1363 | 2303 | OMIM:619326 | BDV SYNDROME; BDVS | | | | | | |
HP:0031508 | HP:0034289 | Elevated circulating rT3/T3 ratio | 1 | DIO1 CL E G H | 1733 | 2883 | OMIM:619855 | | | | | | | |
HP:0031508 | HP:0034288 | Elevated circulating reverse T3 concentration | 1 | DIO1 CL E G H | 1733 | 2883 | OMIM:619855 | | | | | | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 121 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:226316 | Genetic transient congenital hypothyroidism | | | | 121 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | DUOXA2 CL E G H | 405753 | 32698 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 11 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 21 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | IRS4 CL E G H | 8471 | 6128 | OMIM:301035 | HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9; CHNG9 | | | | | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | IYD CL E G H | 389434 | 21071 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 130 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | KCNJ18 CL E G H | 100134444 | 39080 | OMIM:613239 | Thyrotoxic periodic paralysis, susceptibility to, 2 | | | | 10 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | KCNJ18 CL E G H | 100134444 | 39080 | OMIM:613239 | Thyrotoxic periodic paralysis, susceptibility to, 2 | | | | 10 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 51 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 43 | | |
HP:0031508 | HP:0032209 | Abnormal circulating free T3 concentration | 1 | MADD CL E G H | 8567 | 6766 | OMIM:619004 | DEEAH SYNDROME; DEEAH | | | | 5 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | MADD CL E G H | 8567 | 6766 | OMIM:619004 | DEEAH SYNDROME; DEEAH | | | | 5 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 63 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 63 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 63 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | NDN CL E G H | 4692 | 7675 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | NDN CL E G H | 4692 | 7675 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | NDN CL E G H | 4692 | 7675 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | OCA2 CL E G H | 4948 | 8101 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 121 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 121 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 121 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | PAX8 CL E G H | 7849 | 8622 | OMIM:218700 | Hypothyroidism, congenital, nongoitrous, 2 | | | | 63 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 36 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | POU1F1 CL E G H | 5449 | 9210 | OMIM:613038 | Pituitary hormone deficiency, combined, 1 | | | | 36 | | |
HP:0031508 | HP:0032209 | Abnormal circulating free T3 concentration | 1 | POU1F1 CL E G H | 5449 | 9210 | OMIM:613038 | Pituitary hormone deficiency, combined, 1 | | | | 36 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | | | | 54 | | |
HP:0031508 | HP:0032209 | Abnormal circulating free T3 concentration | 1 | SECISBP2 CL E G H | 79048 | 30972 | ORPHA:171706 | Short stature-delayed bone age due to thyroid hormone metabolism deficiency | | | | 3 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | SECISBP2 CL E G H | 79048 | 30972 | ORPHA:171706 | Short stature-delayed bone age due to thyroid hormone metabolism deficiency | | | | 3 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | SECISBP2 CL E G H | 79048 | 30972 | OMIM:609698 | Thyroid hormone metabolism, abnormal | | | | 3 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | SECISBP2 CL E G H | 79048 | 30972 | OMIM:609698 | Thyroid hormone metabolism, abnormal | | | | 3 | | |
HP:0031508 | HP:0032209 | Abnormal circulating free T3 concentration | 1 | SECISBP2 CL E G H | 79048 | 30972 | OMIM:609698 | Thyroid hormone metabolism, abnormal | | | | 3 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | SLC5A5 CL E G H | 6528 | 11040 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 59 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | SNRPN CL E G H | 6638 | 11164 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | | | | 37 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | | | | 37 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | | | | 37 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | TBL1X CL E G H | 6907 | 11585 | OMIM:301033 | Hypothyroidism, congenital, nongoitrous, 8 | | | | 1 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | TG CL E G H | 7038 | 11764 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 155 | | |
HP:0031508 | HP:0012558 | Abnormal T3/T4 ratio | 1 | TG CL E G H | 7038 | 11764 | OMIM:274700 | Thyroid hormonogenesis, genetic defect in, 3 | | | | 155 | | |
HP:0031508 | HP:0012558 | Abnormal T3/T4 ratio | 1 | THRA CL E G H | 7067 | 11796 | OMIM:614450 | Hypothyroidism, congenital, nongoitrous, 6 | | | | 9 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | THRB CL E G H | 7068 | 11799 | OMIM:188570 | Thyroid hormone resistance, generalized, autosomal dominant | | | | 161 | | |
HP:0031508 | HP:0032209 | Abnormal circulating free T3 concentration | 1 | THRB CL E G H | 7068 | 11799 | OMIM:188570 | Thyroid hormone resistance, generalized, autosomal dominant | | | | 161 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | THRB CL E G H | 7068 | 11799 | OMIM:274300 | Thyroid hormone resistance, generalized, autosomal recessive | | | | 161 | | |
HP:0031508 | HP:0033076 | Abnormal circulating free T4 concentration | 1 | THRB CL E G H | 7068 | 11799 | OMIM:274300 | Thyroid hormone resistance, generalized, autosomal recessive | | | | 161 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | TPO CL E G H | 7173 | 12015 | ORPHA:95716 | Familial thyroid dyshormonogenesis | | | | 92 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | TPO CL E G H | 7173 | 12015 | OMIM:274500 | Thyroid hormonogenesis, genetic defect in, 2A | | | | 92 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | TRHR CL E G H | 7201 | 12299 | OMIM:618573 | HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7; CHNG7 | | | | 2 | | |
HP:0031508 | HP:0032209 | Abnormal circulating free T3 concentration | 1 | TRHR CL E G H | 7201 | 12299 | ORPHA:99832 | Resistance to thyrotropin-releasing hormone syndrome | | | | 2 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | TRHR CL E G H | 7201 | 12299 | ORPHA:99832 | Resistance to thyrotropin-releasing hormone syndrome | | | | 2 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | TSHB CL E G H | 7252 | 12372 | ORPHA:90674 | Isolated thyroid-stimulating hormone deficiency | | | | 9 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | TSHR CL E G H | 7253 | 12373 | OMIM:603373 | HYPERTHYROIDISM, FAMILIAL GESTATIONAL | | | | 97 | | |
HP:0031508 | HP:0031505 | Abnormal circulating T4 concentration | 1 | TSHR CL E G H | 7253 | 12373 | ORPHA:90673 | Hypothyroidism due to TSH receptor mutations | | | | 97 | | |
HP:0031508 | HP:0012560 | Decreased T3/T4 ratio | 2 | CL E G H | | | | | | | | | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | ALG8 CL E G H | 79053 | 23161 | OMIM:608104 | Congenital disorder of glycosylation, type Ih | | | | 46 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | HP:0040283 - Occasional | | | 404 | | |
HP:0031508 | HP:0033078 | Decreased circulating free T4 concentration | 2 | CPE CL E G H | 1363 | 2303 | OMIM:619326 | BDV SYNDROME; BDVS | | | | | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040281 - Very frequent | | | 121 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | DUOX2 CL E G H | 50506 | 13273 | ORPHA:226316 | Genetic transient congenital hypothyroidism | HP:0040282 - Frequent | | | 121 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | DUOXA2 CL E G H | 405753 | 32698 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040281 - Very frequent | | | 11 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | HESX1 CL E G H | 8820 | 4877 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 21 | | |
HP:0031508 | HP:0033078 | Decreased circulating free T4 concentration | 2 | IRS4 CL E G H | 8471 | 6128 | OMIM:301035 | HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 9; CHNG9 | | | | | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | IYD CL E G H | 389434 | 21071 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040281 - Very frequent | | | 130 | | |
HP:0031508 | HP:0031506 | Increased circulating T4 concentration | 2 | KCNJ18 CL E G H | 100134444 | 39080 | OMIM:613239 | Thyrotoxic periodic paralysis, susceptibility to, 2 | | | | 10 | | |
HP:0031508 | HP:0033077 | Increased circulating free T4 concentration | 2 | KCNJ18 CL E G H | 100134444 | 39080 | OMIM:613239 | Thyrotoxic periodic paralysis, susceptibility to, 2 | | | | 10 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | LHX3 CL E G H | 8022 | 6595 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 51 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | LHX4 CL E G H | 89884 | 21734 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 43 | | |
HP:0031508 | HP:0032210 | Decreased circulating free T3 | 2 | MADD CL E G H | 8567 | 6766 | OMIM:619004 | DEEAH SYNDROME; DEEAH | | | | 5 | | |
HP:0031508 | HP:0033078 | Decreased circulating free T4 concentration | 2 | MADD CL E G H | 8567 | 6766 | OMIM:619004 | DEEAH SYNDROME; DEEAH | | | | 5 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | HP:0040283 - Occasional | | | 63 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | HP:0040282 - Frequent | | | 63 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | MAGEL2 CL E G H | 54551 | 6814 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | HP:0040282 - Frequent | | | 63 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | NDN CL E G H | 4692 | 7675 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | HP:0040283 - Occasional | | | | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | NDN CL E G H | 4692 | 7675 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | HP:0040282 - Frequent | | | | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | NDN CL E G H | 4692 | 7675 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | HP:0040282 - Frequent | | | | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | OCA2 CL E G H | 4948 | 8101 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | HP:0040283 - Occasional | | | 121 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | HP:0040282 - Frequent | | | 121 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | OCA2 CL E G H | 4948 | 8101 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | HP:0040282 - Frequent | | | 121 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | PAX8 CL E G H | 7849 | 8622 | OMIM:218700 | Hypothyroidism, congenital, nongoitrous, 2 | | | | 63 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | POU1F1 CL E G H | 5449 | 9210 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 36 | | |
HP:0031508 | HP:0033078 | Decreased circulating free T4 concentration | 2 | POU1F1 CL E G H | 5449 | 9210 | OMIM:613038 | Pituitary hormone deficiency, combined, 1 | | | | 36 | | |
HP:0031508 | HP:0032210 | Decreased circulating free T3 | 2 | POU1F1 CL E G H | 5449 | 9210 | OMIM:613038 | Pituitary hormone deficiency, combined, 1 | | | | 36 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | PROP1 CL E G H | 5626 | 9455 | ORPHA:226307 | Hypothyroidism due to deficient transcription factors involved in pituitary development or function | HP:0040282 - Frequent | | | 54 | | |
HP:0031508 | HP:0032210 | Decreased circulating free T3 | 2 | SECISBP2 CL E G H | 79048 | 30972 | ORPHA:171706 | Short stature-delayed bone age due to thyroid hormone metabolism deficiency | | | | 3 | | |
HP:0031508 | HP:0031506 | Increased circulating T4 concentration | 2 | SECISBP2 CL E G H | 79048 | 30972 | ORPHA:171706 | Short stature-delayed bone age due to thyroid hormone metabolism deficiency | | | | 3 | | |
HP:0031508 | HP:0033077 | Increased circulating free T4 concentration | 2 | SECISBP2 CL E G H | 79048 | 30972 | OMIM:609698 | Thyroid hormone metabolism, abnormal | | | | 3 | | |
HP:0031508 | HP:0032210 | Decreased circulating free T3 | 2 | SECISBP2 CL E G H | 79048 | 30972 | OMIM:609698 | Thyroid hormone metabolism, abnormal | | | | 3 | | |
HP:0031508 | HP:0031506 | Increased circulating T4 concentration | 2 | SECISBP2 CL E G H | 79048 | 30972 | OMIM:609698 | Thyroid hormone metabolism, abnormal | | | | 3 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | SLC5A5 CL E G H | 6528 | 11040 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040281 - Very frequent | | | 59 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | SNRPN CL E G H | 6638 | 11164 | ORPHA:98754 | Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 | HP:0040283 - Occasional | | | 37 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177901 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 | HP:0040282 - Frequent | | | 37 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | SNRPN CL E G H | 6638 | 11164 | ORPHA:177904 | Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2 | HP:0040282 - Frequent | | | 37 | | |
HP:0031508 | HP:0033078 | Decreased circulating free T4 concentration | 2 | TBL1X CL E G H | 6907 | 11585 | OMIM:301033 | Hypothyroidism, congenital, nongoitrous, 8 | | | | 1 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | TG CL E G H | 7038 | 11764 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040281 - Very frequent | | | 155 | | |
HP:0031508 | HP:0012559 | Increased T3/T4 ratio | 2 | TG CL E G H | 7038 | 11764 | OMIM:274700 | Thyroid hormonogenesis, genetic defect in, 3 | . | | | 155 | | |
HP:0031508 | HP:0012559 | Increased T3/T4 ratio | 2 | THRA CL E G H | 7067 | 11796 | OMIM:614450 | Hypothyroidism, congenital, nongoitrous, 6 | | | | 9 | | |
HP:0031508 | HP:0011788 | Increased circulating free T3 | 2 | THRB CL E G H | 7068 | 11799 | OMIM:188570 | Thyroid hormone resistance, generalized, autosomal dominant | . | | | 161 | | |
HP:0031508 | HP:0033077 | Increased circulating free T4 concentration | 2 | THRB CL E G H | 7068 | 11799 | OMIM:188570 | Thyroid hormone resistance, generalized, autosomal dominant | | | | 161 | | |
HP:0031508 | HP:0031506 | Increased circulating T4 concentration | 2 | THRB CL E G H | 7068 | 11799 | OMIM:274300 | Thyroid hormone resistance, generalized, autosomal recessive | | | | 161 | | |
HP:0031508 | HP:0033077 | Increased circulating free T4 concentration | 2 | THRB CL E G H | 7068 | 11799 | OMIM:274300 | Thyroid hormone resistance, generalized, autosomal recessive | | | | 161 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | TPO CL E G H | 7173 | 12015 | ORPHA:95716 | Familial thyroid dyshormonogenesis | HP:0040281 - Very frequent | | | 92 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | TPO CL E G H | 7173 | 12015 | OMIM:274500 | Thyroid hormonogenesis, genetic defect in, 2A | | | | 92 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | TRHR CL E G H | 7201 | 12299 | OMIM:618573 | HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 7; CHNG7 | | | | 2 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | TRHR CL E G H | 7201 | 12299 | ORPHA:99832 | Resistance to thyrotropin-releasing hormone syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0031508 | HP:0032210 | Decreased circulating free T3 | 2 | TRHR CL E G H | 7201 | 12299 | ORPHA:99832 | Resistance to thyrotropin-releasing hormone syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | TSHB CL E G H | 7252 | 12372 | ORPHA:90674 | Isolated thyroid-stimulating hormone deficiency | HP:0040281 - Very frequent | | | 9 | | |
HP:0031508 | HP:0031506 | Increased circulating T4 concentration | 2 | TSHR CL E G H | 7253 | 12373 | OMIM:603373 | HYPERTHYROIDISM, FAMILIAL GESTATIONAL | | | | 97 | | |
HP:0031508 | HP:0031507 | Decreased circulating T4 concentration | 2 | TSHR CL E G H | 7253 | 12373 | ORPHA:90673 | Hypothyroidism due to TSH receptor mutations | HP:0040282 - Frequent | | | 97 | | |